Clara Rodríguez Fernández, Author at Labiotech.eu

About

Traveler, musician, food enthusiast and book worm. Always on the hunt for interesting facts and news.

Articles by Clara Rodríguez Fernández

Interview 3 Jul 2019

Meet the First Company in the Brand New Field of Epitranscriptomics

A whole new therapeutic area is taking medical research by storm. In Cambridge, UK, the company Storm Therapeutics is leading the development of the first treatments to target a new layer of genetic information encoded in the RNA. The term ‘epitranscriptomics’ did not exist a decade ago. It was coined in 2012, when scientists started […]

July 3, 2019 - 5 minutesmins - By Clara Rodríguez Fernández

News and Trends 1 Jul 2019

Approval Status of Cancer Cell Therapy at Risk After Halting Phase III Trial

Following an unfavorable interim analysis, Milan-based MolMed has suspended a phase III trial of its cell therapy Zalmoxis that could threaten the conditional marketing authorization the treatment received in 2016. The halted clinical trial was evaluating the effects of Zalmoxis on patients with high-risk leukemia that have received a bone marrow transplant. The cell therapy […]

July 1, 2019 - 2 minutesmins - By Clara Rodríguez Fernández

Spain biotech ecosystem Sanifit Mallorca

News and Trends 26 Jun 2019

Biotech Company in Mallorca Receives Spain’s Largest Biotech Fundraise

Mallorcan biotech Sanifit has broken the record for the largest private fundraise in the Spanish biotech sector raising a total of €72.2M. The fundraising consists of a €55.2M Series D round plus €17M in convertible bonds. The money will be used by Sanifit to fund an upcoming phase III trial of its lead drug candidate […]

June 26, 2019 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 25 Jun 2019

Update: Fund for Late-Stage European Biotechs Closes Final Round With €120M

Update (25/06/2019): The Luxembourg-based investor Vesalius Biocapital III has completed the final closing of a €120M fund to boost late-stage life science companies. Around 10-15 companies will receive investments from the fund, including specialists in drug development, med-tech, and diagnostics. Three companies have become beneficiaries so far, including the Finnish women’s health drug company Forendo […]

June 25, 2019 - 3 minutesmins - By Clara Rodríguez Fernández

Industrial biotechnology companies Europe

Best in Biotech 19 Jun 2019

The Top 20 Industrial Biotechnology Companies in Europe

Europe’s industrial biotechnology sector is driving a massive change from petrochemical processes to more sustainable alternatives. Here are the top industrial biotechnology companies in Europe making every industry greener. Industrial biotechnology draws from biology and the billions of years of evolution behind it to make the production of any chemical compound more efficient and more […]

June 19, 2019 - 8 minutesmins - By Clara Rodríguez Fernández

News and Trends 13 Jun 2019

French Startup to Produce Sustainable Textile Dyes Using Microbes

Paris-based PILI has raised €3.6M that will take its technology to produce dyes through microbial fermentation to an industrial scale. Founded in 2015, PILI seeks to disrupt the unsustainable production of dyes. Just in the textile industry, dyes are a €8B market. However, the production of these chemicals relies on petrochemical processes that require toxic […]

June 13, 2019 - 2 minutesmins - By Clara Rodríguez Fernández

In Depth 11 Jun 2019

Gamma Delta T Cells: A New Hope Against Cancer

A new wave of therapies based on a unique type of immune cells, called gamma delta T cells, has the potential to treat cancer with stronger responses and fewer side effects. Immunotherapies based on T cells are becoming a huge trend in the treatment of cancer, especially CAR-T cells. These genetically-modified T cells have shown […]

June 11, 2019 - 5 minutesmins - By Clara Rodríguez Fernández

Best in Biotech 10 Jun 2019

The 10 Biotech Companies in London to Keep an Eye on in 2019

Which biotechs will be stealing the show this year? These are some of the most exciting biotech companies in London right now. London is undoubtedly one of the biggest hubs for biotech companies in the U.K. and in Europe. The British capital was the one that received the most life sciences investment in Europe in […]

June 10, 2019 - 5 minutesmins - By Clara Rodríguez Fernández

Interview 5 Jun 2019

How Spain is Building a Strong Biotech Ecosystem

The biotech sector is rapidly gaining momentum in Spain. At Labiotech Refresh in Barcelona, Raúl Martín-Ruiz, Partner at the venture capital firm Ysios Capital, shared his experience investing in Spain’s biotech industry over the last decade. Ysios Capital made its first investment in 2008. The recipient was a cell therapy company based in Madrid. Then […]

June 5, 2019 - 4 minutesmins - By Clara Rodríguez Fernández

News and Trends 3 Jun 2019

‘CRISPR Babies’ Might Be at Risk of Dying Younger

Update (01/10/2019): The scientists behind the study have declared that the results were based on erroneous data, meaning the mutation they studied has a weaker effect on mortality than initially reported. A new study highlights the issues that can result from modifying human DNA without sufficient understanding of how it can impact our health. Last […]

June 3, 2019 - 3 minutesmins - By Clara Rodríguez Fernández

Interview 30 May 2019

Taking Inspiration from Plants to Prevent Mold from Ruining Crops

Olga Dubey founded the Swiss startup Agrosustain with the intention to bring forth a natural alternative to chemical pesticides against mold. She shares how it all started and her company’s plans to end the massive amounts of food waste that mold is responsible for. “Mold is everywhere, so it’s something that is very hard to […]

May 30, 2019 - 4 minutesmins - By Clara Rodríguez Fernández

Interview 28 May 2019

Getting Ahead of the Pack in the CAR-T Field

Celyad is one of many companies in the immuno-oncology field seeking to take the lead in the development of a new generation of CAR-T cell therapy that outperforms its predecessors Yescarta and Kymriah in both efficacy and safety. Filippo Petti, CEO of Celyad, shares the company’s strategy to get ahead in such a crowded field. […]

May 28, 2019 - 6 minutesmins - By Clara Rodríguez Fernández

Resources

Categories

The twelve hottest biotech companies in the Boston area

Biotech bankruptcies: what to expect in 2024 following a record year?

Approaches

Therapeutic areas

RNA editing set to take off: could it outperform gene editing?

Future of cancer treatment: what will therapy look like in 2034?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us